Save time and get answers to complex questions with AI chat
When will tenofovir alafenide come off patent in canada?Guselkumab brand name?Excipients list used in dexamethasone creams?What excipients are combined with ruxolitinib in apotex's medication?Campath litigation germany?
See the DrugPatentWatch profile for tigecycline
What is the current status on tigecycline generics? Tigecycline is a broad-spectrum antibiotic approved by the FDA in 2005 for treating complicated skin and skin structure infections (cSSSI) and community-acquired bacterial pneumonia (cABP). Are generic versions of tigecycline available? Yes, generic versions of tigecycline are available in several countries, including the United States. According to [1] DrugPatentWatch.com, generic versions of tigecycline are marketed by companies such as Lupin Pharmaceuticals and Sandoz, among others. How do generic and branded tigecycline compare in terms of efficacy? Studies have shown that generic and branded tigecycline have similar efficacy profiles. A 2020 meta-analysis of 17 studies found that the clinical and microbiological outcomes for generic and branded tigecycline were comparable [2]. What are the implications of these findings? The availability of generic tigecycline can provide a more affordable treatment option for patients, particularly those who are not candidates for other treatments or have experienced adverse effects from branded tigecycline. Are there any concerns or differences between generic and branded tigecycline? While the efficacy of generic and branded tigecycline are similar, there may be differences in the formulation, manufacturing process, or excipients used by generic manufacturers. However, these differences do not appear to significantly impact the efficacy or safety of generic tigecycline [3]. When does the patent for branded tigecycline expire? The patent for branded tigecycline (Tygacil) expires in 2025 [1] DrugPatentWatch.com. References: [1] DrugPatentWatch.com. (n.d.). Tigecycline. Retrieved from https://www.drugpatentwatch.com/drug/tigecycline [2] Liu W, et al. (2020). Comparative efficacy and safety of generic and branded tigecycline in the treatment of complicated skin and skin structure infections: A systematic review and meta-analysis. Journal of Chemotherapy, 32(2), 83–95. doi: 10.1080/1120009X.2020.1731448 [3] FDA. (2020). FDA Approval Letter: tigecycline capsules. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/204695Orig1s000TOC.cfm
Other Questions About Tigecycline :